Vanguard Group »

Stoke Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.7M 1.6M 5.26
2023-09-30 $6.4M 1.6M 3.94
2023-06-30 $17M 1.6M 10.63
2023-03-31 $9.4M 1.1M 8.33
2022-12-31 $15M 1.6M 9.23
2022-06-30 $26M 2.0M 13.21
2022-03-31 $41M 1.9M 21.05
2021-09-30 $47M 1.8M 25.44
2021-06-30 $59M 1.7M 33.65
2021-03-31 $65M 1.7M 38.84
2020-12-31 $99M 1.6M 61.91
2020-09-30 $44M 1.3M 33.49
2020-06-30 $31M 1.3M 23.82
2020-03-31 $18M 796k 22.90
2019-12-31 $22M 773k 28.32
2019-09-30 $15M 674k 21.50